{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:58:51Z","timestamp":1788317931585,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T00:00:00Z","timestamp":1701475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T00:00:00Z","timestamp":1701475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Disease-related stress can trigger the occurrence of herpes zoster (HZ). Fatty liver disease (FLD) can have adverse effects on the human body and may induce stress in affected individuals. In this study, we investigated whether FLD is associated with an elevated risk of HZ.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>For this study, we utilized data from the National Health Insurance Research Database, patients with FLD from 2000 to 2017 were observed (follow-up until 2018). Patients were considered to have FLD if they had at least two outpatient visits or at least one admission record with a diagnostic code of FLD. Patients with FLD were matched 1:1 by age, sex, comorbidities, and index year with control patients. Additionally, the FLD was further categorized into non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD) groups. Multivariable Cox proportional hazards model was used to calculate the incidence rate and adjusted hazard ratio (aHR) of HZ for FLD and AFLD and for various age groups, sex and comorbidities. Cumulative incidence curve for HZ was plotted through the Kaplan\u2013Meier method, and p-value was calculated using the log-rank test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After 1:1 propensity-score matching, each cohort comprised 62,418 patients. The FLD cohort was further divided into NAFLD and AFLD groups, which respectively comprised 55,709 and 6709 patients. The FLD cohort had a risk of HZ significantly higher than that of the control cohort (aHR\u2009=\u20091.06; p\u2009&lt;\u20090.001). Additionally, the NAFLD group exhibited a significantly higher risk of HZ than did the AFLD group (aHR\u2009=\u20091.22; p\u2009&lt;\u20090.001). Among patients without any comorbidities, those with FLD had a higher risk of HZ than did those without FLD (aHR\u2009=\u20091.14; p\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Patients with FLD are at an increased risk of HZ development. Additionally, NAFLD is associated with a higher risk of HZ than AFLD. Therefore, patients with NAFLD should be informed of their increased risk of HZ.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01524-6","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T09:02:12Z","timestamp":1701507732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease"],"prefix":"10.1186","volume":"28","author":[{"given":"Cheng-Wei","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Che","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Ju","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuu-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yu","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,2]]},"reference":[{"issue":"17","key":"1524_CR1","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1001\/jama.2019.2276","volume":"321","author":"T Wong","year":"2019","unstructured":"Wong T, Dang K, Ladhani S, Singal AK, Wong RJ. Prevalence of alcoholic fatty liver disease among adults in the United States, 2001\u20132016. JAMA. 2019;321(17):1723\u20135. https:\/\/doi.org\/10.1001\/jama.2019.2276.","journal-title":"JAMA"},{"key":"1524_CR2","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0365","author":"ML Teng","year":"2022","unstructured":"Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, Yang JD, Tan E, Muthiah MD. Global incidence and prevalence of non-alcoholic fatty liver disease. Clin Mol Hepatol. 2022. https:\/\/doi.org\/10.3350\/cmh.2022.0365.","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"1524_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389\u201398. https:\/\/doi.org\/10.1016\/S2468-1253(19)30039-1.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"1524_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, Yang H, Liu C, Kam LY, Tan XXE, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(8):739\u201352. https:\/\/doi.org\/10.1016\/S2468-1253(20)30077-7.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"1524_CR5","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1080\/21645515.2020.1847582","volume":"17","author":"D van Oorschot","year":"2021","unstructured":"van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B. A systematic literature review of herpes zoster incidence worldwide. Hum Vaccin Immunother. 2021;17(6):1714\u201332. https:\/\/doi.org\/10.1080\/21645515.2020.1847582.","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"1524_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6): e004833. https:\/\/doi.org\/10.1136\/bmjopen-2014-004833.","journal-title":"BMJ Open"},{"issue":"7","key":"1524_CR7","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1093\/cid\/ciz1090","volume":"71","author":"SL McKay","year":"2020","unstructured":"McKay SL, Guo A, Pergam SA, Dooling K. Herpes zoster risk in immunocompromised adults in the United States: a systematic review. Clin Infect Dis. 2020;71(7):e125\u201334. https:\/\/doi.org\/10.1093\/cid\/ciz1090.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1524_CR8","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.3390\/ijerph20032656","volume":"20","author":"CA Wang","year":"2023","unstructured":"Wang CA, Chen CH, Hsieh WC, Hsu TJ, Hsu CY, Cheng YC, Hsu CY. Risk of herpes zoster in patients with pulmonary tuberculosis - a population-based cohort study. Int J Environ Res Public Health. 2023;20(3):2656. https:\/\/doi.org\/10.3390\/ijerph20032656.","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"1524_CR9","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1111\/jdv.13175","volume":"29","author":"CY Hsu","year":"2015","unstructured":"Hsu CY, Wang YC, Kao CH. Dyshidrosis is a risk factor for herpes zoster. J Eur Acad Dermatol Venereol. 2015;29(11):2177\u201383. https:\/\/doi.org\/10.1111\/jdv.13175.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"1524_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259942","volume":"16","author":"CY Hsu","year":"2021","unstructured":"Hsu CY, Ke DS, Lin CL, Kao CH. Plantar fascial fibromatosis and herpes zoster. PLoS ONE. 2021;16(11): e0259942. https:\/\/doi.org\/10.1371\/journal.pone.0259942.","journal-title":"PLoS ONE"},{"issue":"12","key":"1524_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046891","volume":"11","author":"CY Hsu","year":"2021","unstructured":"Hsu CY, Ke DS, Lin CL, Kao CH. Association between de Quervain syndrome and herpes zoster: a population-based cohort study. BMJ Open. 2021;11(12): e046891. https:\/\/doi.org\/10.1136\/bmjopen-2020-046891.","journal-title":"BMJ Open"},{"issue":"1","key":"1524_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/00325481.2020.1816713","volume":"133","author":"CY Hsu","year":"2021","unstructured":"Hsu CY, Ke DS, Lin CL, Kao CH. Association between lateral epicondylitis and the risk of herpes zoster development. Postgrad Med. 2021;133(1):96\u2013101. https:\/\/doi.org\/10.1080\/00325481.2020.1816713.","journal-title":"Postgrad Med"},{"key":"1524_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.584322","volume":"8","author":"CY Hsu","year":"2021","unstructured":"Hsu CY, Ke DS, Lin CL, Kao CH. To investigate the risk of herpes zoster in women with endometriosis: a Taiwan national population-based cohort study. Front Med (Lausanne). 2021;8: 584322. https:\/\/doi.org\/10.3389\/fmed.2021.584322.","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"1524_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/00325481.2021.1893066","volume":"133","author":"CY Hsu","year":"2021","unstructured":"Hsu CY, Ke DS, Lin CL, Kao CH. Risk of herpes zoster infection in men with varicocele. Postgrad Med. 2021;133(6):599\u2013603. https:\/\/doi.org\/10.1080\/00325481.2021.1893066.","journal-title":"Postgrad Med"},{"issue":"1","key":"1524_CR15","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/S2589-7500(22)00187-X","volume":"5","author":"V Kuan","year":"2023","unstructured":"Kuan V, Denaxas S, Patalay P, Nitsch D, Mathur R, Gonzalez-Izquierdo A, Sofat R, Partridge L, Roberts A, Wong ICK, et al. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study. Lancet Digit Health. 2023;5(1):e16\u201327. https:\/\/doi.org\/10.1016\/S2589-7500(22)00187-X.","journal-title":"Lancet Digit Health"},{"key":"1524_CR16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.pnpbp.2015.09.001","volume":"65","author":"T Barr","year":"2016","unstructured":"Barr T, Helms C, Grant K, Messaoudi I. Opposing effects of alcohol on the immune system. Prog Neuropsychopharmacol Biol Psychiatry. 2016;65:242\u201351. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.09.001.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"1524_CR17","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/aje\/kwab027","volume":"190","author":"SAJ Schmidt","year":"2021","unstructured":"Schmidt SAJ, S\u00f8rensen HT, Langan SM, Vestergaard M. Associations of lifestyle and anthropometric factors with the risk of herpes zoster: a nationwide population-based cohort study. Am J Epidemiol. 2021;190(6):1064\u201374. https:\/\/doi.org\/10.1093\/aje\/kwab027.","journal-title":"Am J Epidemiol"},{"key":"1524_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/164_2017_88","volume":"248","author":"A Kim","year":"2018","unstructured":"Kim A, McCullough RL, Poulsen KL, Sanz-Garcia C, Sheehan M, Stavitsky AB, Nagy LE. Hepatic immune system: adaptations to alcohol. Handb Exp Pharmacol. 2018;248:347\u201367. https:\/\/doi.org\/10.1007\/164_2017_88.","journal-title":"Handb Exp Pharmacol"},{"issue":"39","key":"1524_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008179","volume":"96","author":"W Dai","year":"2017","unstructured":"Dai W, Ye L, Liu A, Wen SW, Deng J, Wu X, Lai Z. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis. Medicine (Baltimore). 2017;96(39): e8179. https:\/\/doi.org\/10.1097\/MD.0000000000008179.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"1524_CR20","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","volume":"70","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501022 adult individuals. Gut. 2021;70(5):962\u20139. https:\/\/doi.org\/10.1136\/gutjnl-2020-322572.","journal-title":"Gut"},{"issue":"4","key":"1524_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","volume":"10","author":"N Stefan","year":"2022","unstructured":"Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol. 2022;10(4):284\u201396. https:\/\/doi.org\/10.1016\/S2213-8587(22)00003-1.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1524_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2022.108168","volume":"36","author":"N Chuanchaiyakul","year":"2022","unstructured":"Chuanchaiyakul N, Thongtang N, Rattanaumpawan P. Cumulative incidence of and risk factors for herpes zoster among patients with diabetes mellitus: results from a 10-year nested case-control study. J Diabetes Complications. 2022;36(5): 108168. https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108168.","journal-title":"J Diabetes Complications"},{"issue":"2","key":"1524_CR23","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1210\/clinem\/dgab675","volume":"107","author":"CT Huang","year":"2022","unstructured":"Huang CT, Lee CY, Sung HY, Liu SJ, Liang PC, Tsai MC. Association between diabetes mellitus and the risk of herpes zoster: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2022;107(2):586\u201397. https:\/\/doi.org\/10.1210\/clinem\/dgab675.","journal-title":"J Clin Endocrinol Metab"},{"key":"1524_CR24","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/155017","author":"Y Chen","year":"2022","unstructured":"Chen Y, Bai W, Mao D, Long F, Wang N, Wang K, Shi Q. The relationship between non-alcoholic fatty liver disease and incidence of chronic kidney disease for diabetic and non-diabetic subjects: a meta-analysis. Adv Clin Exp Med. 2022. https:\/\/doi.org\/10.17219\/acem\/155017.","journal-title":"Adv Clin Exp Med"},{"issue":"10","key":"1524_CR25","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/hep4.1408","volume":"3","author":"MH Le","year":"2019","unstructured":"Le MH, Yeo YH, Henry L, Nguyen MH. Nonalcoholic fatty liver disease and renal function impairment: a cross-sectional population-based study on its relationship from 1999 to 2016. Hepatol Commun. 2019;3(10):1334\u201346. https:\/\/doi.org\/10.1002\/hep4.1408.","journal-title":"Hepatol Commun"},{"issue":"6","key":"1524_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4093\/dmj.2017.41.6.430","volume":"41","author":"E Han","year":"2017","unstructured":"Han E, Lee YH. Non-alcoholic fatty liver disease: the emerging burden in cardiometabolic and renal diseases. Diabetes Metab J. 2017;41(6):430\u20137. https:\/\/doi.org\/10.4093\/dmj.2017.41.6.430.","journal-title":"Diabetes Metab J"},{"issue":"10","key":"1524_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13566","volume":"74","author":"SW Lai","year":"2020","unstructured":"Lai SW, Kuo YH, Lin CL, Liao KF. Risk of herpes zoster among patients with predialysis chronic kidney disease in a cohort study in Taiwan. Int J Clin Pract. 2020;74(10): e13566. https:\/\/doi.org\/10.1111\/ijcp.13566.","journal-title":"Int J Clin Pract"},{"issue":"9","key":"1524_CR28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/vaccines9090963","volume":"9","author":"Z Li","year":"2021","unstructured":"Li Z, Wang Q, Ma J, Li Z, Huang D, Huang Y, Zhou H. Risk factors for herpes zoster in patients with chronic kidney disease: a case-control study. Vaccines (Basel). 2021;9(9):963. https:\/\/doi.org\/10.3390\/vaccines9090963.","journal-title":"Vaccines (Basel)"},{"key":"1524_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.985803","volume":"9","author":"CH Ng","year":"2022","unstructured":"Ng CH, Xiao J, Chew NWS, Chin YH, Chan KE, Quek J, Lim WH, Tan DJH, Loke RWK, Tan C, et al. Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality. Front Med (Lausanne). 2022;9: 985803. https:\/\/doi.org\/10.3389\/fmed.2022.985803.","journal-title":"Front Med (Lausanne)"},{"issue":"301","key":"1524_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jad.2021.12.128","volume":"15","author":"Y Gu","year":"2022","unstructured":"Gu Y, Zhang W, Hu Y, Chen Y, Shi J. Association between nonalcoholic fatty liver disease and depression: a systematic review and meta-analysis of observational studies. J Affect Disord. 2022;15(301):8\u201313. https:\/\/doi.org\/10.1016\/j.jad.2021.12.128.","journal-title":"J Affect Disord"},{"issue":"9","key":"1524_CR31","doi-asserted-by":"publisher","first-page":"e1099","DOI":"10.4088\/JCP.14m09311","volume":"76","author":"CH Liao","year":"2015","unstructured":"Liao CH, Chang CS, Muo CH, Kao CH. High prevalence of herpes zoster in patients with depression. J Clin Psychiatry. 2015;76(9):e1099\u2013104. https:\/\/doi.org\/10.4088\/JCP.14m09311.","journal-title":"J Clin Psychiatry"},{"issue":"40","key":"1524_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017430","volume":"98","author":"HG Choi","year":"2019","unstructured":"Choi HG, Kim EJ, Lee YK, Kim M. The risk of herpes zoster virus infection in patients with depression: a longitudinal follow-up study using a national sample cohort. Medicine (Baltimore). 2019;98(40): e17430. https:\/\/doi.org\/10.1097\/MD.0000000000017430.","journal-title":"Medicine (Baltimore)"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01524-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01524-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01524-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T09:03:10Z","timestamp":1701507790000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01524-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1524"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01524-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,2]]},"assertion":[{"value":"20 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of Ditmanson Medical Foundation, Chia-Yi Christian Hospital, Chia-Yi, Taiwan (approval number: IRB2023016). Due to the use of de-identified patient information from the National Health Insurance Research Database, the informed consent was waived by the Institutional Review Board of Ditmanson Medical Foundation, Chia-Yi Christian Hospital, Chia-Yi, Taiwan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"550"}}